Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways

References

• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18. doi:10.1038/s41572-019-0069-0
   PubMed Web of Science ®Google Scholar
• Ashbaugh D, Bigelow DB, Petty T, Levine B. Acute respiratory distress in adults. Lancet. 1967;290(7511):319–323. doi:10.1016/S0140-6736(67)90168-7
   Google Scholar
• Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345–350. doi:10.5858/arpa.2015-0519-RA
   PubMed Web of Science ®Google Scholar
• Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800. doi:10.1001/jama.2016.0291
   PubMed Web of Science ®Google Scholar
• Sevransky JE, Levy MM, Marini JJ. Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S548–53. doi:10.1097/01.CCM.0000145947.19077.25
   PubMedGoogle Scholar
• Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276. doi:10.1016/S2213-2600(19)30417-5
   PubMed Web of Science ®Google Scholar
• Levy BD, Serhan CN. Resolution of acute inflammation in the lung. Annu Rev Physiol. 2014;76:467–492. doi:10.1146/annurev-physiol-021113-170408
   PubMed Web of Science ®Google Scholar
• Lee JW, Chun W, Lee HJ, et al. The role of macrophages in the development of acute and chronic inflammatory lung diseases. Cells. 2021;10(4):897. doi:10.3390/cells10040897
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a001651
   PubMed Web of Science ®Google Scholar
• Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol. 1999;20(4):751–758. doi:10.1165/ajrcmb.20.4.3420
   PubMed Web of Science ®Google Scholar
• Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722. doi:10.3389/fimmu.2020.01722
   PubMed Web of Science ®Google Scholar
• Ge-Sang CR, Yu RY. Acute toxicity study of Tibetan medicine Sichen formula. J Med Pharm Chins Minor. 2014;20(10):48. doi:10.16041/j.cnki.cn15-1175.2014.10.029 [in Chinese]
   Google Scholar
• Qin LY, Cai MR, Yao Y, et al. HPLC fingerprints of Tibetan medicine Sichen Zhike granules. Central South Pharm. 2021;19(03):507–512. doi:10.7539/j.issn.1672-2981.2021.03.023 [in Chinese]
   Google Scholar
• Wang JL, Zhou HY, Dun, Z, Pan, D. Pharmacodynamic research on antitussive effect of Tibet medicine Si Chen Zhi Ke Granule. Chin J Tradit Chin Med Pharm. 2007;22(12):895–898. [in Chinese]
   Google Scholar
• Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010;24(5):417–422. doi:10.1007/s10822-010-9352-6
   PubMed Web of Science ®Google Scholar
• Mirzapoiazova T, Kolosova IA, Moreno L, Sammani S, Garcia JG, Verin AD. Suppression of endotoxin-induced inflammation by taxol. Eur Respir J. 2007;30(3):429–435. doi:10.1183/09031936.00154206
   PubMed Web of Science ®Google Scholar
• Tsai CL, Lin YC, Wang HM, Chou TC. Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats. J Ethnopharmacol. 2014;153(1):197–206. doi:10.1016/j.jep.2014.02.010
   PubMed Web of Science ®Google Scholar
• Luo G, Cheng BC, Zhao H, et al. Schisandra Chinensis Lignans suppresses the production of inflammatory mediators regulated by NF-κB, AP-1, and IRF3 in Lipopolysaccharide-stimulated RAW264.7 cells. Molecules. 2018;23(12):3319. doi:10.3390/molecules23123319
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chi-Yan Cheng B, Xie R, Xu B, Gao XY, Luo G. Re-Du-Ning inhalation solution exerts suppressive effect on the secretion of inflammatory mediators via inhibiting IKKα/β/IκBα/NF-κB, MAPKs/AP-1, and TBK1/IRF3 signaling pathways in lipopolysaccharide stimulated RAW 264.7 macrophages. RSC Adv. 2019;9(16):8912–8925. doi:10.1039/C9RA00060G
   PubMed Web of Science ®Google Scholar
• Malik K, Ahmad M, Zhang G, et al. Traditional plant based medicines used to treat musculoskeletal disorders in Northern Pakistan. Eur J Intergr Med. 2018;19:17–64. doi:10.1016/j.eujim.2018.02.003
   Web of Science ®Google Scholar
• Yue Y, Li Q, Fu Y, Chang J. Stability of chlorogenic acid from artemisiae scopariae herba enhanced by natural deep eutectic solvents as green and biodegradable extraction media. ACS Omega. 2021;6(50):34857–34865. doi:10.1021/acsomega.1c05541
   PubMed Web of Science ®Google Scholar
• Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008;22(6):709–724. doi:10.1002/ptr.2362
   PubMed Web of Science ®Google Scholar
• Chen H, Jiang Z. The essential adaptors of innate immune signaling. Protein Cell. 2013;4(1):27–39. doi:10.1007/s13238-012-2063-0
   PubMed Web of Science ®Google Scholar
• Hu R, Xu H, Jiang H, Zhang Y, Sun Y. The role of TLR4 in the pathogenesis of indirect acute lung injury. Front Biosci. 2013;18(4):1244–1255. doi:10.2741/4176
   Google Scholar
• Yan LS, Cheng BC, Zhang SF, et al. Tibetan medicine for diabetes mellitus: overview of pharmacological perspectives. Front Pharmacol. 2021;12:748500. doi:10.3389/fphar.2021.748500
   PubMed Web of Science ®Google Scholar
• Fu K, Xu M, Zhou Y, et al. The Status quo and way forwards on the development of Tibetan medicine and the pharmacological research of Tibetan materia Medica. Pharmacol Res. 2020;155:104688. doi:10.1016/j.phrs.2020.104688
   PubMed Web of Science ®Google Scholar
• Yang S, Yu Z, Wang L, et al. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activation. J Ethnopharmacol. 2017;200:147–155. doi:10.1016/j.jep.2017.02.013
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang H, Yang T, et al. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Injury. 2010;41(7):746–752. doi:10.1016/j.injury.2010.02.029
   PubMed Web of Science ®Google Scholar
• Shi JR, Mao LG, Jiang RA, Qian Y, Tang HF, Chen JQ. Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice. Int Immunopharmacol. 2010;10(10):1235–1241. doi:10.1016/j.intimp.2010.07.004
   PubMed Web of Science ®Google Scholar
• Maus U, von Grote K, Kuziel WA, et al. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med. 2002;166(3):268–273. doi:10.1164/rccm.2112012
   PubMed Web of Science ®Google Scholar
• Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993;81(6):1607–1613. doi:10.1182/blood.V81.6.1607.1607
   PubMed Web of Science ®Google Scholar
• Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun. 2005;73(3):1754–1763. doi:10.1128/IAI.73.3.1754-1763.2005
   PubMed Web of Science ®Google Scholar
• Murakami A, Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 2007;121(11):2357–2363. doi:10.1002/ijc.23161
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol. 2011;12(8):695–708. doi:10.1038/ni.2065
   PubMed Web of Science ®Google Scholar
• Yang H, Young DW, Gusovsky F, Chow JC. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem. 2000;275(27):20861–20866. doi:10.1074/jbc.M002896200
   PubMed Web of Science ®Google Scholar
• Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med. 2004;199(12):1651–1658. doi:10.1084/jem.20040528
   PubMed Web of Science ®Google Scholar